Company intelligence / Profile preview

Innovative Omics

Ownership: Private
Development stage: Other

Overview

Innovative Omics develops advanced data processing services and software tools to support state-of-the-art measurement in omics fields, with special expertise in wearable exposure monitors, PFAS analysis, non-targeted contaminant detection, and lipidomics. Their platforms are used by researchers for comprehensive measurement solutions in human health and environmental science.

Modalities: LipidomicsPFAS analysisNon-targeted contaminant analysis
Industry: Biomedical IT and Biomedical Data Platforms

Partnerships

Avanti Polar LipidsAgilent

Beyond the preview

Go deeper on Innovative Omics.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Innovative Omics.

Explore the full profile